Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Endometrial Neoplasms 3 Obesity 2 Endometrial Hyperplasia 2 Weight Loss 1 Prostatic Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Opioid-Related Disorders 1 Lymphoma, Follicular 1 Hyperplasia 1 Breast Neoplasms 1

Interventions

anamorelin 2 Mirtazapine 2 Tirzepatide 1 Olanzapine 1 Octreotide 1 Nutritionists 1 Nutrition Assessment 1 Flurandrenolone 1 Exercise 1 EOM613 1 Diet, Carbohydrate-Restricted 1 Diet 1 Acetylcysteine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Weight Loss × Tirzepatide × Clear all

NCT06518837 2026-01-21

FITWISE

Rutgers, The State University of New Jersey

Phase 2 Recruiting

Weight Loss

Data powered by HemOnc (CC BY 4.0) Colophon ⚡